Innovation intelligence brief
Innovation intelligence brief
Price-optimizing InsurTech where insurers see how much they can charge to each consumer.
What became of it
Blocked · Low confidence · Last verified 2026-10-17
Research is blocked: there was not enough public evidence to establish what became of this innovation. Nothing below should be read as a verified 2026 status.
As catalogued
Portuguese price-optimisation insurtech selling non-life insurers a software platform, pricing methodology and proprietary competitor and customer data (collected via experimental design) to set the most profitable individual price per customer.
2026 reality
Not established. The website data-xl.com returns only a JavaScript redirect to '/lander' (a pattern typical of parked domains) in October 2026; the only located company description is an undated Wellfound profile. Targeted searches found no funding, client, press or registry evidence.
No evidenced change found.
individual price optimisation has come under regulatory pressure in Europe (e.g. price-walking bans), which limits the relevance of this model.
REVIEW · Re-checked data-xl.com (redirect to '/lander', likely parked) and searched again without finding any company evidence; record stays BLOCKED, website observation refined.
Documented evidence
Homepage
Products
Research interpretation
Classification paths, as catalogued, connect this example to the original insurance digitalization research models.